Background: Boron neutron capture therapy (BNCT) is a cellular-level particle radiation therapy that combines the selective delivery of boron compounds to tumour tissue with neutron irradiation. L-p-Boronophenylalanine (L-BPA) is a boron compound now widely used in clinical situations. Determination of the boron distribution is required for successful BNCT prior to neutron irradiation. Thus, positron emission tomography with [
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Conclusions:
No difference was noted in the time course of the boron concentrations in tumour tissue and normal tissues between L-BPA and [ 19 F]-L-FBPA. However, the administration protocol had effects on the normal tissue to blood ratio of the boron concentration. In estimating the BNCT dose in normal tissue by positron emission tomography (PET), we should consider the possible overestimation of the normal tissue to blood ratio of the boron concentrations derived from the values measured by PET on dose calculation. 
Background
Boron neutron capture therapy (BNCT) is based on the nuclear reaction of the 10 B nucleus, which absorbs lowenergy neutrons to produce two high-linear-energy transfer particles ( 4 He, 163 keV/μm and 7 Li, 210 keV/ μm) from the 10 B(n, α) 7 Li reaction. The track ranges of these particles (5-9 μm) are limited to the diameter of a single cell. Theoretically, therefore, if 10 B atoms are selectively accumulated in each tumour cell, and then the volume including the tumour is exposed to a sufficiently high fluence of thermal neutrons, targeting single tumour cells with less normal tissue damage than conventional therapy is possible [1] . Two boron compounds, disodium mercaptoundecahydrododecaborate (Na 2 B 12 H 11 SH; BSH) [2] and L-p-boronophenylalanine (L-BPA) [3] , have been clinically utilized for the treatment of patients with various types of X-ray-refractory cancers such as malignant melanoma [4] , malignant brain tumours [5] [6] [7] [8] [9] , recurrent head and neck cancer [10, 11] , and malignant mesothelioma [12] . In contrast to other types of radiotherapy, the cytocidal effect of BNCT on tumour tissue depends on the selective accumulation of boron compounds in the tumour. Thus, imaging methods that can illuminate the distribution of boron compounds noninvasively are important to forecast the efficacy of BNCT.
o-[ F-labelled radiopharmaceutical analogue of L-BPA used as a positron emission tomography (PET) probe to estimate the L-BPA distribution in BNCT using L-BPA prior to treatment [13] . This "theranostic approach", which combines diagnostic modalities such as PET imaging and a therapeutic procedure such as neutron irradiation with boron compounds, is useful to confirm the irradiation dose from the boron neutron capture reaction and calculate the estimated tumour dose beforehand to assure safety and efficacy. However, the method used to evaluate the boron concentrations predicted by [ (Fig. 1) . Actually, the degree of solubility in water and affinity to L-BPA antibodies were different between L-BPA for BNCT and [ 
Methods

Materials
Optically pure [ 19 F]-L-FBPA was synthesised by a hybrid process using L-aminoacylase from commercially available 2-fluoro-4-dihydroxyborylbenzaldehyde (Additional file 1: Figure S1 ). The water solubility of L-BPA and [ 19 F]-L-FBPA were measured from supernatant of saturated solution by UV absorption method. SCC-VII, a squamous cell carcinoma cell line derived from C3H/He mice (Department of Radiology, Kyoto University), was maintained in Eagle's minimum essential medium supplemented with 12.5 % foetal bovine serum and penicillin/streptomycin (100 U/mL). The cells were cultured at 37°C with 5 % CO 2 .
Four-week-old female C3H/He mice were purchased from CLEA Japan (Tokyo, Japan). SCC-VII cells ]-L-FBPA-fructose solution (500 mg/ kg body weight) was subcutaneously injected into mice into the nuchal sites after a 3-h fast [17] . At each time point (30 min, 1, 2, 3, and 4 h), the boron concentrations in the blood, normal tissue, and tumour tissue were evaluated. Five mice were used for each time point. Totally 25 mice were used in this experiment. The 20 % trimmed mean, which was defined as the mean after discarding samples at the high and low end, was used to evaluate the difference between L-BPA and [
19 F]-L-FBPA in order to improve non-normality and skew in population distribution in this study. Time courses of the boron compounds in blood and tissues were defined as bioequivalent if the 90 % confidence intervals for the ratios of the average values of parameters fall within the acceptance limits of 0.80-1.25 for the maximum concentration and areas under the blood boron concentration curve (AUC) [18] . ]-L-FBPA-fructose solution (500 mg/ kg body weight) was continuously and subcutaneously injected at a constant rate of drip infusion into the nuchal sites after a 3-h fast using a syringe pump (KDS100; Muromachi Kikai Co., Ltd., Tokyo, Japan) without anaesthesia. Totally seven mice (four mice of L-BPA group and three mice of [ 19 F]-L-FBPA group) were used in this experiment. First, each fructose solution of boron compound was continuously infused at a rate of 200 mg/kg body weight/h for 2 h. Next, the infusion rate was reduced to 100 mg/kg body weight/h for 1 h as in the clinical protocol for human patients previously reported [19] . After 3 h from the onset of drip infusion, tissue samples were excised immediately, and the boron concentrations in the blood, normal tissue, and tumour tissue were measured.
Measurements of the boron concentration
Blood and tissue samples were digested with perchloric acid (60 %) and hydrogen peroxide (30 %) for 24 h at 75°C. The boron concentration in each sample was determined by ICP-AES (iCAP 6000; Thermo Fisher Scientific Inc., Massachusetts, USA) and was normalized as μg/g. The N/B, T/B, and T/N ratios were calculated, and the 20 % trimmed mean values of each ratio were used for statistical analysis.
Statistical analysis
The data are expressed as the mean ± standard deviation. The differences between the L-BPA group and [
19 F]-L-FBPA group and the subcutaneous injection group and continuous injection group were analysed by Welch's ttest. The differences of N/B, T/B, and T/N ratio between the values 3 h after a single injection in Experiment 1 and the values after continuous drip infusion in Experiment 2 were analysed by a non-parametric ANOVA. P values less than 0.05 were considered to be statistically significant. All of the statistical analyses were performed using JMP Pro 11 software (SAS Institute Inc., Cary, NC, USA). The 90 % confidence intervals of AUC in blood, intestine, liver, lung, tongue, skin, muscle, brain, and tumour were 1.33, 1.08, 1.05, 1.08, 1.22, 1.29, 1.13, 1.08, and 1.07, respectively. The 90 % confidence intervals of the maximum concentration of boron in blood were within ranges of 0.80-1.25, while that of AUC in blood were out of the ranges. That of the maximum concentrations and AUC in liver and tumour were within the ranges. However, that of the maximum concentrations in intestine, tongue, and muscle were out of the ranges, while that of AUC in these organs were within the ranges. Table 2 . There were no significant differences in the boron concentrations between the L-BPA group and [
Results
Properties
19 F]-L-FBPA group. Table 3 , Fig. 3 (black circles at the time point of 3 h) 19 F]-L-FBPA group was also the same regarding the T/N ratio under the continuous-infusion protocol (Table 4 and Fig. 4 ).
Experiment 1 and 2: comparison between the singleinjection protocol and continuous-infusion protocol
Comparing the single-injection protocol and continuousinfusion protocol, the N/B and T/N ratios of the continuous-infusion group were different from those of the single-injection group (Fig. 3) . The N/B ratio of the continuous-infusion protocol was lower than that of the single-injection protocol, while the T/N ratio of the continuous-infusion protocol was higher than that of the single-injection protocol. In contrast, the T/B ratio of the continuous-infusion protocol corresponded with that of the single-injection protocol at 1, 2, and 3 h after L-BPA or [
19 F]-L-FBPA injection (Fig. 3) . N/B, T/B, and T/N ratio of liver and tumour tissue had no statistical difference between administration protocols both in L-BPA group and L-FBPA group. On the other hand, N/B and T/N ratio of tongue, muscle, and brain had significant difference between administration protocols both in L-BPA group and L-FBPA group (Figs. 3 and 4) .
Discussion
This study is the first examination comparing the pharmacokinetics of L-BPA and 19 F]-L-FBPA. Two aspects in the present study are particularly different from the data of previous studies. First, organs that include air such as the intestine and lung could be evaluated without underestimation by the same protocol in both the L-BPA group and [
19 F]-L-FBPA group in this study. In particular, [ 18 F]-L-FBPA accumulation in hollow organs or the lung is significantly underestimated by PET based on the maximum or average counts [16] . In this study, the boron concentrations of the intestine and lung showed no significant difference between the L-BPA group and Comparing the single-injection protocol with the continuous-infusion protocol, the T/N ratio by the continuous-infusion protocol was higher than that by the single-injection protocol in many normal tissues such as the brain, tongue, lung, intestine, skin, and muscle (Fig. 3) . The N/B ratio in those normal tissues with the continuous-infusion protocol was lower than that by the single-injection protocol measured 1 h after injection. However, the N/B and T/N ratios of the liver and the T/B ratio were almost the same between the continuous-infusion protocol and single-injection protocol (Fig. 3) . In this study, we used continuous subcutaneous injection protocol instead of continuous intravenous injection protocol. This is because we concerned the possible effects of anesthesia during continuous intravenous injection to circulation dynamics, blood flow, and tissue distribution of boron compounds. The biological effectiveness of neutron capture therapy depends on the administration dose of L-BPA [17, 22] and the N/ B ratio [22, 23] . In this study, we found a difference in the N/B and T/B ratios between the single-injection protocol and continuous-infusion protocol. In applying the N/B or T/N ratios measured by the [ 18 F]-L-FBPA PET study to dosimetry in the clinical setting, we should consider the possibility of the difference between administration protocols. Further studies, including pharmacokinetic studies with various animal species, treatment studies using neutron irradiation with different administration protocols, and examinations regarding the difference in the biological effectiveness using the infusion protocol, are needed to presisely estimate the pharmacokinetics in humans and to define both offset values between the values measured by PET and tumour dosimetry in clinical situations and appropriate time points of PET values after the single injection of [ 18 F]-L-FBPA. There are some limitations to this study. First, our measurement methods by ICP-AES could not evaluate the microdistribution of boron atoms in tissue components. GM Morris and colleagues showed the different microdistribution patterns of boron atoms in murine tongue mucosa following the administration of L-BPA or BSH [24] . BNCT is based on the neutron capture reaction resulting in two particles ( 4 He and 7 Li) whose range is limited to the diameter of a single cell (5-9 μm). Therefore, microdistribution impacts both tumour targeting and normal tissue damage. In this study, we did not evaluate microdistribution because we focused on the equivalence of However, microdistribution should be examined in evaluating treatment results or the equivalence of biological effects rather than the pharmacokinetics of boron compounds [25] .
The 
